Abstract
Objective Many studies that have estimated the breast cancer risk attributable to family history have been based on data collected within family units. Use of this study design has likely overestimated risks for the general population. We provide population-based estimates of breast cancer risk and different tumor subtypes in relation to the degree, number, and age at diagnosis of affected relatives. Methods Cox Proportional Hazards to calculate risks (hazard ratios; 95% confidence interval) of breast cancer and tumor subtypes for women with a family history of breast cancer relative to women without a family history among a cohort of 75,189 women age ≥40 years of whom 1,087 were diagnosed with breast cancer from June 1, 2001–December 31, 2005 (median follow-up 3.16 years). Results Breast cancer risk was highest for women with a first-degree family history (1.54; 1.34–1.77); and did not differ substantially by the affected relative’s age at diagnosis or by number of affected first-degree relatives. A second-degree family history only was not associated with a significantly increased breast cancer risk (1.15; 0.98–1.35). There was a suggestion that a positive family history was associated with risk of triple positive (Estrogen+/Progesterone+/HER2+) and HER2-overexpressing tumors. Conclusions While a family history of breast cancer in first-degree relatives is an important risk factor for breast cancer, gathering information such as the age at diagnosis of affected relatives or information on second-degree relative history may be unnecessary in assessing personal breast cancer risk among women age ≥40 years.
Similar content being viewed by others
References
Sattin RW, Rubin GL, Webster LA et al (1985) Family history and the risk of breast cancer. JAMA 253(13):1908–1913
Colditz GA, Willett WC, Hunter DJ et al (1993) Family history, age and risk of breast cancer: prospective data from the nurses’ health study. JAMA 270(3):338–343
Parazzini F, La Vecchia C, Negri E et al (1993) Family history of breast, ovarian and endometrial cancer and risk of breast cancer. Int J Epidemiol 22(4):614–618
Muhonen T, Eerola H, Vehmanen P et al (1997) Breast cancer risk estimation in families with history of breast cancer. Br J Cancer 76(9):1228–1231
Negri E, Braga C, La Vecchia C et al (1997) Family history of cancer and risk of breast cancer. Int J Cancer 72(5):735–738
Pharoah PDP, Day NE, Duffy S et al (1997) Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 71(5):800–809
Anderson H, Bladström A, Olsson H et al (2000) Familial breast and ovarian cancer: a Swedish population-based register study. Am J Epidemiol 152(12):1154–1163
Dumitrescu RG, Cotarla I (2005) Understanding breast cancer risk—where do we stand in 2005? J Cell Mol Med 9(1):208–221
Hopper JL, Bishop DT, Easton DF (2005) Population-based family studies in genetic epidemiology. Lancet 366(9494):1397–1406
Crest AB, Aiello EJ, Anderson ML et al (2006) Varying levels of family history of breast cancer in relation to mammographic breast density (United States). Cancer Causes Control 17(6):843–850
Lehrer S, Lee P, Tartter P et al (1995) Breast cancer and family history: a multivariate analysis of levels of tumor HER2 protein and family history of cancer in women who have breast cancer. Mt Sinai J Med 62(6):415–418
Tutera AM, Sellers TA, Potter JD et al (1996) Association between family history of cancer and breast cancer defined by estrogen and progesterone receptor status. Genet Epidemiol 13(2):207–221
Huang WY, Newman B, Millikan RC et al (2000) Risk of breast cancer according to the status of HER-2/neu oncogene amplification. Cancer Epidemiol Biomarkers Prev 9(1):65–71
Gavrilov I, Nacheva M, Tzingilev D (2002) Familial breast cancer. Part II: relationships with histology, staging, steroid receptors and serum tumor markers. J BUON 7(1):61–65
Yang XR, Sherman ME, Rimm DL et al (2007) Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Biomarkers Prev 16(3):439–443
Althuis MD, Fergenbaum JH, Garcia-Closas M et al (2004) Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev 13(10):1558–1568
Sørlie T, Perou CM, Tibshirani R et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98(19):10869–10874
Carey LA, Perou CM, Livasy CA et al (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295(21):2492–2502
Taplin SH, Thompson RS, Schnitzer F et al (1990) Revisions in the risk-based Breast Cancer Screening Program at Group Health Cooperative. Cancer 66(4):812–818
Taplin SH, Mandelson MT, Anderman C et al (1997) Mammography diffusion and trends in late-state breast cancer: evaluating outcomes in a population. Cancer Epidemiol Biomarkers Prev 6(8):625–631
Taplin SH, Ichikawa L, Buist DS et al (2004) Evaluating organized breast cancer screening implementation: the prevention of late-state disease? Cancer Epidemiol Biomarkers Prev 13(2):225–234
Group Health Cooperative Breast Cancer Screening Schedule (1992) Available via: http://www.centerforhealthstudies.org/surveillanceproject/overview/screening-schedule.html. Cited 9 April 2008
Cox DR, Oakes D (1984) Analysis of survival data. Chapman & Hall, London
Perou CM, Sørlie T, Elsen MB et al (2000) Molecular portraits of human breast tumours. Nature 406(6797):747–752
Sørlie T, Tibshirani R, Parker J et al (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 100(14):8418–8423
American College of Radiology (2003) Breast imaging reporting and data system (BI-RADS™), 4th edn. American College of Radiology, Reston, VA
Hosmer DW, Lemeshow S (1999) Applied Survival analysis: regression modeling of time to event data. John Wiley, Inc., New York
StataCorp (2005) Stata statistical software: release 9. StataCorp LP, College Station, TX
Collaborative Group on Hormonal Factors in Breast Cancer (2001) Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 358(9291):1389–1399
Calle EE, Martin LM, Thun MJ et al (1993) Family history, age, and risk of fatal breast cancer. Am J Epidemiol 138(9):675–681
Ziogas A, Anton-Culver H (2003) Validation of family history data in cancer family registries. Am J Prev Med 24(2):190–198
Murff HJ, Spigel DR, Syngal S (2004) Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA 292(12):1480–1489
Coliditz GA, Rosner BA, Chen WY et al (2004) Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst 96(3):218–228
Swede H, Moysich KB, Freudenheim JL et al (2001) Breast cancer risk factors and HER2 over-expression in tumors. Cancer Detect Prev 25(6):511–519
Cooper JA, Rohan TE, Cant EL et al (1989) Risk factors for breast cancer by oestrogen receptor status: a population-based case–control study. Br J Cancer 59(1):119–125
Lakhani SR, Van De Vijver MJ, Jacquemier J et al (2002) The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 20(9):2310–2318
Sellers TA, Kushi LH, Potter JD et al (1993) Effect of family history, body-fat distribution, and reproductive factors on the risk of postmenopausal breast cancer. N Engl J Med 326(20):1323–1329
Yankaskas BC (2005–2006) Epidemiology of breast cancer in young women. Breast Dis 23(1):3–8
Ries LAG, Melbert D, Krapcho M et al. (2007) SEER cancer statistics review, 1975–2004. National Cancer Institute, Bethesda, MD. http://seer.cancer.gov/csr/1975_2004/, based on November 2006 SEER data submission, posted to the SEER web site
Hall IJ, Burke W, Coughlin S et al (2001) Population-based estimates of the prevalence of family history of cancer among women. Community Genet 4(3):134–142
Acknowledgements
The authors wish to acknowledge Julia Hecht and Walter Clinton for their assistance in creating the dataset used in our analyses. Funding/Support: Design and conduct of the study; collection, management, and interpretation of the data; review and approval of the manuscript were supported by the Breast Cancer Surveillance Consortium: Breast Cancer Surveillance in a Defined Population from the National Cancer Institute (CA063731), D. Buist, Principal Investigator. Analysis of the data and manuscript preparation were supported by the UW Multidisciplinary Predoctoral Clinical Research Training Program—a Roadmap Initiative from the National Institutes of Health/National Center for Research Resources (T32 RR023256), P. Mitchell and S. Marshall, Program Directors.
Author information
Authors and Affiliations
Corresponding author
Appendices
Appendices
Rights and permissions
About this article
Cite this article
Welsh, M.L., Buist, D.S.M., Aiello Bowles, E.J. et al. Population-based estimates of the relation between breast cancer risk, tumor subtype, and family history. Breast Cancer Res Treat 114, 549–558 (2009). https://doi.org/10.1007/s10549-008-0026-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-008-0026-1